Zimmer Introduces the Zimmer(R) Natural Nail(TM) Cephalomedullary Nail System

Latest in Line of Intramedullary Nails Features Anatomic Design Focused on Restoring Patients' Anatomy

MADRID, June 4, 2010 - Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal
care, today introduced the Zimmer Natural Nail Cephalomedullary Nail System
to the European market at the 11th annual EFORT (European Federation of
National Associations of Orthopaedics and Traumatology) Congress. The
Cephalomedullary Nail is designed to help address fractures of the femur,
especially intertrochanteric and subtrochanteric fractures. This latest
addition to the Zimmer Natural Nail System joins the Tibial Nail which has
been commercially available since February, 2009.

"Since no two fractures are the same, it's important that surgeons have
access to options which ensure the best possible fixation for all patient
types," said Bob Peterhans, President, Zimmer Trauma. "From tip to tip, the
design of the Zimmer Natural Nail Cephalomedullary Nail System focuses on
restoring and stabilizing the anatomy. Surgeons utilizing the
Cephalomedullary Nail can expect precise and easy-to-use instrumentation that
minimizes the potential for inaccuracies."

Building on the strengths of the Zimmer Natural Nail System, the
Cephalomedullary Nail features an anatomically contoured implant and
intuitive instrumentation capable of addressing the needs of patients of all
shapes and sizes. Central to the design of the Cephalomedullary Nail is its
anatomic shape which helps restore patients to their natural, pre-injury
state. The Cephalomedullary Nail provides fixation to help restore the
natural shape of the femur, and features a small proximal section designed to
minimize the amount of bone that must be removed for nail insertion.

The Cephalomedullary Nail features Zimmer's StabiliZe Technology and
optimized screw locations to help better link the nail to bone. Screws are
placed throughout the implant to further secure it and maintain length and
alignment during the healing process. A choice of short and long nails, as
well as nails of different diameters and center-column-diaphyseal (CCD)
angles are available to best match the individual anatomy of the patient. To
enhance ease-of-use, the Cephalomedullary Nail instrumentation features
color-coded instrumentation to aid surgical staff during the procedure.

The Zimmer Natural Nail System is a next-generation line of
intramedullary nails, screws, instruments and other associated implants
designed to provide stable fixation for fractured long bones during fracture
healing.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs,
develops, manufactures and markets orthopaedic reconstructive, spinal and
trauma devices, dental implants, and related surgical products. Zimmer has
operations in more than 25 countries around the world and sells products in
more than 100 countries. Zimmer's 2009 sales were approximately US$4.1
billion. The Company is supported by the efforts of more than 8,000 employees
worldwide.

For more information about Zimmer, visit www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995
based on current expectations, estimates, forecasts and projections about the
orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "assumes," "guides,"
"targets," "forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These statements are not
guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ
materially. For a list and description of such risks and uncertainties, see
our periodic reports filed with the U.S. Securities and Exchange Commission.
We disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as may be set forth in our periodic reports.
Readers of this document are cautioned not to place undue reliance on these
forward-looking statements, since, while we believe the assumptions on which
the forward-looking statements are based are reasonable, there can be no
assurance that these forward-looking statements will prove to be accurate.
This cautionary statement is applicable to all forward-looking statements
contained in this document.

Media contacts: Sabine Ciccotosto, +41 (0)52-262-72-41, sabine.ciccotosto at zimmer.com; Investor contact, James T. Crines, +1-574-372-4264, james.crines at zimmer.com, and Paul Blair, +1-574-371-8042, paul.blair at zimmer.com